References
- Lau Y L, Chan L C, Chan A YY, Ha S Y, Yeung C Y, Waye J S, Chui D HK. Prevalence and genotypes of α‐ and β‐thalassemia carriers in Hong Kong—implications for population screening. N Engl J Med 1997; 336(18)1298–1301
- Olivieri N F. The β‐thalassemias. N Eng J Med 1999; 341(2)99–109
- Ma E SK, Chan A YY, Au W Y, Yeung Y M, Chan L C. Diagnosis of concurrent Hb H disease and heterozygous β‐thalassaemia. Haematologica 2001; 86(4)432–433
- Fleming P S, Hughes W G, Farmile R K, Wyatt K, Coopers W N. Hemoglobin Westmead (α2 122 (H5) His→Gln β2: a new hemoglobin variant with the substitution in the α1β1 contact area. Hemoglobin 1980; 4(1)39–52
- Jiang N H, Liang S, Wen X J, Liang R, Su C, Tang Z. Hb Westmead: an α2‐globin gene mutation detected by polymerase chain reaction and Stu I cleavage. Hemoglobin 1991; 15(4)291–295
- Liang S, Tang Z, Su C, Lung Q, Liang R, Fei Y J, Kutlar F, Wilson J B, Webber B B, Hu H, Huisman T HJ. Hb Duan [α75(EF4)Asp > Ala], Hb Westmead [α122(H5)His > Gln], and α‐thalassemia‐2 (− 4.2 kb deletion) in a Chinese family. Hemoglobin 1988; 12(1)13–21
- Gu Y‐C, Gu L‐H, Wilson J B, Cepreganova B, Ramachandran M, Walker E LD, III, Huisman T HJ, Potitong P. Hb Westmead [α122(H5)His > Gln], Hb E [β26(B8)Glu > Lys], and α‐thalassemia‐2 (3.7 kb deletion) in a Laotian family. Hemoglobin 1991; 15(4)297–302
- Ma E SK, Chow E YD, Chan A YY, Chan L C. Interaction between (– –SEA) α‐thalassemia deletion and uncommon non‐deletional α‐globin mutations in Chinese patients. Haematologica 2001; 86(5)539–540
- Loukopoulos D, Loutradi A, Fessas P. A unique thalassaemic syndrome: homozygous α‐thalassaemia + homozygous β‐thalassaemia. Br J Haematol 1978; 39(3)377–389
- Furbetta M, Galanello R, Ximenes A, Angius A, Melis M A, Serra P, Cao A. Interaction of α and β thalassaemia genes in two Sardinian families. Br J Haematol 1979; 41(2)203–210
- Kanavakis E, Traeger‐Synodinos J, Lafiniatis S, Liakopoulou Th, Metaxotou A, Stamoulakatou A, Papassotiriou I. A rare and unusual thalassaemia intermedia with co‐inheritance of β‐thalassaemia major and Hb H disease. Hematol J 2003; 4(suppl 2)51, (abstract 0142)